These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19372293)

  • 41. D3 receptor agonist efficacy in restless legs syndrome.
    Casoni F; Galbiati A; Ferini-Strambi L
    Adv Pharmacol; 2019; 84():21-35. PubMed ID: 31229173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
    Geyer J; Bogan R
    Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recognition, diagnosis, and treatment of restless legs syndrome.
    Smith JE; Tolson JM
    J Am Acad Nurse Pract; 2008 Aug; 20(8):396-401. PubMed ID: 18786013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restless legs syndrome in the older adult: diagnosis and management.
    Milligan SA; Chesson AL
    Drugs Aging; 2002; 19(10):741-51. PubMed ID: 12390051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic Utility of Opioids for Restless Legs Syndrome.
    Mackie SE; Winkelman JW
    Drugs; 2017 Aug; 77(12):1337-1344. PubMed ID: 28616844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
    Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
    Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between restless leg syndrom and slow coronary flow.
    Erden İ; Çakcak Erden E; Durmuş H; Tıbıllı H; Tabakçı M; Kalkan ME; Türker Y; Akçakoyun M
    Anadolu Kardiyol Derg; 2014 Nov; 14(7):612-6. PubMed ID: 25036324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The restless legs syndrome can be treated with dopamine agonists].
    Aramideh M; de Weerd AW
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2173-7. PubMed ID: 17061425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cannabis for Restless Legs Syndrome.
    Ghorayeb I
    Adv Exp Med Biol; 2021; 1297():173-181. PubMed ID: 33537945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is restless legs syndrome underrecognized? Current management.
    Vergne-Salle P; Coyral D; Dufauret K; Bonnet C; Bertin P; Trèves R
    Joint Bone Spine; 2006 Jul; 73(4):369-73. PubMed ID: 16213771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical management of restless legs syndrome in end-stage renal disease patients.
    Sahli ZT; Jo J; Mousa SA; Tarazi FI
    CNS Spectr; 2017 Feb; 22(1):14-21. PubMed ID: 27702420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Diagnosis and symptom rating scale of restless legs syndrome].
    Inoue Y
    Brain Nerve; 2009 May; 61(5):533-8. PubMed ID: 19514513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical pharmacology and efficacy of rotigotine (Neupro® patch) in the treatment of restless leg syndrome.
    Ferini-Strambi L; Marelli S; Galbiati A
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):967-75. PubMed ID: 27224246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Restless legs syndrome and periodic limb movements in sleep: pathophysiology and treatment].
    Wichniak A; Wierzbicka A; Jernajczyk W
    Neurol Neurochir Pol; 2003; 37(3):633-43. PubMed ID: 14593758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Restless legs syndrome: treatment with dopaminergic agents.
    Comella CL
    Neurology; 2002 Feb; 58(4 Suppl 1):S87-92. PubMed ID: 11909990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pramipexole in the treatment of restless legs syndrome: a follow-up study.
    Montplaisir J; Denesle R; Petit D
    Eur J Neurol; 2000 May; 7 Suppl 1():27-31. PubMed ID: 11054156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restless legs syndrome.
    Bayard M; Avonda T; Wadzinski J
    Am Fam Physician; 2008 Jul; 78(2):235-40. PubMed ID: 18697508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacotherapy for restless legs syndrome.
    Ferini-Strambi L; Marelli S
    Expert Opin Pharmacother; 2014 Jun; 15(8):1127-38. PubMed ID: 24745717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.